Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.

Abroad (travel likely)Recruiting

Conditions

Prostate Cancer · Radiotherapy Side Effect · Hypofractionation · Brachytherapy · Radiotherapy · Localized Prostate Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHUdeQuebec, Québec, Canada
Contact: Study coordinator (Andre-Guy Martin, MD,MSc,FRCPC) · Andre-Guy.Martin.med@ssss.gouv.qc.ca · 1-418-691-5264
Contact: Study coordinator (Josée Allard, MSc) · Josee.Allard@chuq.qc.ca · 1-418-691-5264
Contact: Principal Investigator (Andre-Guy Martin, MD,MSc,FRCPC)

Study leads

Andre-Guy Martin
Study Chair
CHU de Québec

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Prostate Cancer (Adenocarcinoma) · Prostate CA · Prostate Cancers

Abroad (travel likely)RecruitingPHASE2

Chicago, United States · Gahanna, United States

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors · Triple Negative Breast Cancer (TNBC) · HR+ Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Denver, United States · Houston, United States

Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer

Metastatic Castration Resistant Prostate Cancer

Abroad (travel likely)Recruiting

Konstanz, Germany · Stuttgart, Germany

Stem Cells for Erectile Dysfunction Post RALP

Erectile Dysfunction · Prostate Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States